Efficacy and safety of Subetta add-on therapy in type 1 diabetes mellitus: The results of a multicenter, double-blind, placebo-controlled, randomized clinical trial-Reference-Cited by-同舟云学术

Efficacy and safety of Subetta add-on therapy in type 1 diabetes mellitus: The results of a multicenter, double-blind, placebo-controlled, randomized clinical trial

Published:2018-08 Issue: Volume:142 Page:1-9
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Mkrtumyan Ashot,Romantsova Tatyana,Vorobiev Sergei,Volkova Anna,Vorokhobina Natalia,Tarasov Sergey,Putilovskiy Mikhail,Andrianova Elena,Epstein Oleg

Funder

OOO “NPF “MATERIA MEDICA HOLDING”

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference23 articles.

1. American Diabetes Association. Standards of medical care in diabetes - 2017. Diabetes Care 2017;40(Suppl. 1):S1–2. http://doi.org/10.2337/dc17-S001.

2. Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes;Matuleviciene-Anangen;Heart,2017

3. Pursuit of a perfect insulin;Zaykov;Nat Rev Drug Discov,2016

4. Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2014;(2) [Art. No.: CD009122]. http://doi.org/10.1002/14651858.CD009122.pub2.

5. Will the next generation of basal insulins offer clinical advantages?;Garber;Diabetes Obes Metab,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of physical treatment on physicochemical and biological properties of water and aqueous solutions;Fine Chemical Technologies;2023-11-26

2. Modeling of protein hydration dynamics is supported by THz spectroscopy of highly diluted solutions;Frontiers in Chemistry;2023-06-09

3. The Role of MHC Class I and Class II Molecules in Antibacterial Immunity and Treatment of Bacterial Diseases;Antibiotics and Chemotherapy;2022-11-18

4. Technologically-Treated Polyclonal Affinity-Purified Antibodies to the Tumor Necrosis Factor-α, Brain Specific S-100 Protein and Histamine in Treatment of Functional Dyspepsia: Results of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial;Russian Journal of Gastroenterology, Hepatology, Coloproctology;2022-08-11

5. Therapeutic potential of highly diluted antibodies in antibiotic-resistant infection;European Journal of Pharmaceutical Sciences;2022-06